Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

80.76 

-1.84 -2.2%

as of Aug 23 '19

52 Week Range:

71.83 103.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Equity (BVPS) 17.20
16.86
17.04
18.34
18.35
19.49
22.98
23.26
growth rate -2.0% 1.1% 7.6% 0.1% 3.1% 8.6% 1.2%
Earnings BIT 64.35
50.59
153.33
181.10
273.27
305.99
320.02
378.74
growth rate -21.4% 203.1% 18.1% 22.8% 5.8% 4.6% 18.4%
Avg.PE 2,000.00
52.91
27.86
33.81
26.04
25.87
29.49
77.50
growth rate -97.4% -47.3% 21.4% -12.2% -0.3% 14.0% 162.8%
ROA 0.22
1.81
4.26
3.91
5.12
5.55
5.64
3.94
growth rate 722.7% 135.4% -8.2% 31.0% 4.1% 0.8% -30.1%
ROE 0.41
3.70
8.50
7.82
10.23
10.99
12.57
9.35
growth rate 802.4% 129.7% -8.0% 30.8% 3.7% 7.0% -25.6%
ROIC 0.88
3.50
7.61
6.36
7.88
8.55
8.16
6.65
growth rate 297.7% 117.4% -16.4% 23.9% 4.2% -2.3% -18.5%
Cur. Ratio 1.44
1.67
1.73
1.79
1.84
1.97
1.26
1.60
growth rate 16.0% 3.6% 3.5% 2.8% 3.5% -20.0% 27.0%
Quick Ratio 0.92
1.08
1.07
1.08
1.21
1.30
0.79
1.03
growth rate 17.4% -0.9% 0.9% 12.0% 3.7% -22.1% 30.4%
Leverage 2.08
2.01
1.98
2.02
1.97
1.99
2.43
2.31
growth rate -3.4% -1.5% 2.0% -2.5% 0.5% 10.5% -4.9%
Balance Sheet Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Acct.Receivable 409.90
457.01
466.75
470.56
415.06
425.59
552.30
632.67
growth rate 11.5% 2.1% 0.8% -6.1% 1.3% 29.8% 14.6%
Acct.Payable 556.97
570.56
173.95
140.98
168.03
222.09
220.95
growth rate 2.4% -69.5% -10.0% 9.2% 32.2% -0.5%
Cur.Assets 883.10
971.75
1,044.84
1,068.55
1,033.16
1,189.93
1,199.96
1,234.63
growth rate 10.0% 7.5% 2.3% -1.7% 7.3% 0.8% 2.9%
Total Assets 3,855.60
3,901.76
3,946.71
4,127.58
4,166.30
4,276.68
6,091.46
5,975.52
growth rate 1.2% 1.2% 4.6% 0.5% 1.3% 42.4% -1.9%
Cash 142.30
171.44
173.24
174.82
237.93
359.27
202.13
163.11
growth rate 20.5% 1.1% 0.9% 16.7% 22.9% -43.7% -19.3%
Inventory 240.80
247.69
260.86
285.46
259.49
246.85
351.68
338.35
growth rate 2.9% 5.3% 9.4% -4.7% -2.5% 42.5% -3.8%
Cur.Liabilities 598.70
581.10
602.80
597.31
561.49
603.36
950.90
771.63
growth rate -2.9% 3.7% -0.9% -3.1% 3.7% 57.6% -18.9%
Liabilities 2,013.40
1,961.95
1,952.23
2,085.47
2,055.85
2,123.11
3,588.28
3,390.57
growth rate -2.6% -0.5% 6.8% -0.7% 1.6% 69.0% -5.5%
LT Debt 944.90
938.82
932.10
1,007.19
974.66
1,009.35
1,754.30
1,843.64
growth rate -0.6% -0.7% 8.1% -1.6% 1.8% 73.8% 5.1%
Equity 1,842.20
1,939.81
1,994.49
2,042.10
2,110.44
2,153.57
2,503.19
2,584.96
growth rate 5.3% 2.8% 2.4% 1.7% 1.0% 16.2% 3.3%
Common Shares 114.00
115.00
114.00
114.00
112.03
109.62
109.62
111.00
112.00
growth rate 0.9% -0.9% 0.0% -1.7% -1.1% 0.0% 1.3% 0.9%
Cash Flow Statement Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Capital Expenditures -0.50
42.40
38.98
27.15
28.22
31.70
39.09
93.25
growth rate 100.0% -8.1% -30.4% 1.9% 6.0% 23.3% 138.6%
Cash Dividends 31.80
31.90
31.60
31.62
31.57
30.80
30.79
31.01
growth rate 0.3% -1.0% 0.1% -0.1% -1.2% 0.0% 0.7%
Cash From OA 224.90
152.17
158.59
281.60
287.10
350.62
288.45
311.04
growth rate -32.3% 4.2% 77.6% 1.0% 10.5% -17.7% 7.8%
FCF per Share 1.18
0.96
0.67
2.00
2.06
2.61
2.53
1.82
growth rate -18.6% -30.2% 198.5% 3.0% 12.6% -1.5% -28.1%
Sale Purchase of Stock 30.37
-107.09
24.46
14.91
14.42
18.00
growth rate -100.0% 100.0% -21.9% -1.7% 24.9%
FCF 194.00
110.00
119.00
253.00
257.00
258.88
319.00
318.91
249.00
218.00
growth rate -43.3% 8.2% 112.6% 1.6% 0.7% 23.2% 0.0% -21.9% -12.5%
Income Statement Jan '11 Dec '11 Dec '12 Dec '13 Dec '14 Oct '15 Jan '16 Oct '16 Jan '17 Oct '17 Dec '18
Sales 1,918.50
2,105.19
2,157.59
2,069.88
2,104.82
2,115.52
2,256.98
2,778.00
growth rate 9.7% 2.5% -4.1% 0.8% 0.3% 6.7% 23.1%
Op.Income 91.10
71.29
174.27
181.10
273.27
305.99
320.02
378.74
growth rate -21.8% 144.5% 3.9% 22.8% 5.8% 4.6% 18.4%
IBT 64.40
55.16
163.68
123.87
208.81
244.07
296.72
257.68
growth rate -14.3% 196.7% -24.3% 29.8% 8.1% 21.6% -13.2%
Net Income 7.70
71.29
174.27
157.78
212.43
234.30
292.63
237.93
growth rate 825.8% 144.5% -9.5% 16.0% 5.0% 24.9% -18.7%
EPS 0.07
0.61
1.47
1.39
1.87
2.12
2.64
2.13
growth rate 771.4% 141.0% -5.4% 34.5% 6.5% 11.6% -19.3%
Gross Profit 847.80
961.53
976.14
937.02
971.51
1,014.76
1,079.94
1,360.21
growth rate 13.4% 1.5% -4.0% 1.8% 2.2% 6.4% 26.0%
R&D 115.80
131.84
132.40
108.06
112.54
124.18
139.46
194.00
growth rate 13.9% 0.4% -18.4% 2.1% 5.1% 12.3% 39.1%

Quarterly Statements

Item Name Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Earnings BIT 62.74
95.65
109.79
67.85
106.06
growth rate 52.5% 14.8% -38.2% 56.3%
Balance Sheet Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 575.74
551.39
632.67
623.93
654.45
growth rate -4.2% 14.7% -1.4% 4.9%
Acct.Payable 215.40
180.69
220.95
219.34
188.05
growth rate -16.1% 22.3% -0.7% -14.3%
Cur.Assets 1,234.00
1,165.50
1,234.63
1,247.65
1,337.76
growth rate -5.6% 5.9% 1.1% 7.2%
Total Assets 6,126.19
5,862.36
5,975.52
6,086.50
6,399.07
growth rate -4.3% 1.9% 1.9% 5.1%
Cash 180.80
149.51
163.11
134.25
150.02
growth rate -17.3% 9.1% -17.7% 11.7%
Inventory 374.81
354.24
338.35
376.51
414.33
growth rate -5.5% -4.5% 11.3% 10.1%
Cur.Liabilities 925.98
686.75
771.63
742.27
706.80
growth rate -25.8% 12.4% -3.8% -4.8%
Liabilities 3,570.93
3,289.89
3,390.57
3,448.03
3,692.21
growth rate -7.9% 3.1% 1.7% 7.1%
LT Debt 1,825.50
1,849.10
1,843.64
1,848.94
2,104.47
growth rate 1.3% -0.3% 0.3% 13.8%
Equity 2,555.25
2,572.47
2,584.96
2,638.47
2,706.87
growth rate 0.7% 0.5% 2.1% 2.6%
Common Shares 110.62
111.09
110.60
110.89
111.07
growth rate 0.4% -0.4% 0.3% 0.2%
Cash Flow Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 22.65
20.84
32.81
19.88
16.59
growth rate -8.0% 57.5% -39.4% -16.6%
Cash Dividends 7.73
7.75
7.79
7.74
7.76
growth rate 0.3% 0.5% -0.6% 0.3%
Cash From OA -14.56
93.19
159.42
-5.32
46.86
growth rate 100.0% 71.1% -100.0% 100.0%
Sale Purchase of Stock 7.47
0.88
growth rate -88.2%
FCF -37.21
72.36
126.61
-25.19
30.27
growth rate 100.0% 75.0% -100.0% 100.0%
Income Statement Apr '18 Jul '18 Dec '18 Mar '19 Jun '19
Sales 643.97
674.31
756.35
648.74
722.52
growth rate 4.7% 12.2% -14.2% 11.4%
Op.Income 62.74
95.65
109.79
67.85
106.06
growth rate 52.5% 14.8% -38.2% 56.3%
IBT 28.51
78.04
79.43
36.77
71.83
growth rate 173.8% 1.8% -53.7% 95.4%
Net Income 26.02
76.55
71.29
35.41
69.09
growth rate 194.1% -6.9% -50.3% 95.1%
EPS
growth rate
Gross Profit 301.43
332.33
377.36
308.09
353.09
growth rate 10.3% 13.6% -18.4% 14.6%
R&D 45.98
48.85
51.97
47.98
48.34
growth rate 6.2% 6.4% -7.7% 0.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (31.30)

YOY Growth Grade:

E (31.30)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 42.32 36.31 20.46
EPS / Growth 9.1% 2.22 13.9%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 5.6%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 5.6% 9.5% 9.5%
Future PE 11.12 27.28 27.28
Future EPS 3.82 5.53 5.53
Value Price
MOS %
10.50
-87.0%
37.27
-53.9%
37.27
-53.9%
MOS Price 5.25 18.63 18.63
IRT 19.75 15.65 15.65

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.